Cingulate CING
NASDAQ CING
$4.57 +0.13 (+2.81%)
As of: Nov 10, 2026 · 12:45 PM EST

Cingulate (CING) Receivables - Other (2024 - 2026)

Updated

Cingulate's Receivables - Other was $38,447 in Q2 2026, up 96.3% from $19,585 a year earlier.

Analysis

Cingulate (CING) Receivables - Other (2024 - 2026) Analysis & Trends

At the end of FY2025, Receivables - Other at Cingulate came in at $8,013, down 69.6% from FY2024.

  • In earlier years, Receivables - Other was $26,325 in FY2024.
  • The Q2 2026 figure marks the highest quarterly Receivables - Other since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Cingulate 63.03 Mn -8.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38,447.00
Dec 31, 2025 8,013.00
Sep 30, 2025 19,041.00
Jun 30, 2025 19,585.00
Mar 31, 2025 41,573.00
Dec 31, 2024 26,325.00
API Access

Cingulate Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=CING&period=max&api_key=YOUR_API_KEY